|
Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
Introduction
|
Why do we need guidelines on valvular heart disease?, Contents of these guidelines, How to use these guidelines, Method of review, Definition of levels of recommendation |
General comments
|
Patient evaluation, Clinical evaluation, Echocardiography, Fluoroscopy, Radionuclide angiography, Stress testing, Other non-invasive imaging techniques, Biomarkers, oronary angiography, Cardiac catheterization, Assessment of comorbidity, Endocarditis prophylaxis, Risk stratification
|
Aortic regurgitation
|
Introduction, Evaluation, Natural history, Results of surgery, Indications for surgery, Medical therapy,
Serial testing, Special patient populations
|
Aortic stenosis
|
Introduction, Evaluation, Natural history, Results of intervention, Indications for surgery,
Indications for balloon valvuloplasty, Medical therapy, Serial testing, Special patient populations
|
Mitral regurgitation
|
Organic mitral regurgitation, Evaluation, Natural history, Results of surgery, Indications for intervention,
Medical therapy, Serial testing, Ischaemic mitral regurgitation, Evaluation, Natural history, Results of surgery, Indications for surgery, Functional mitral regurgitation |
Mitral stenosis
|
Introduction, Evaluation, Natural history, Results of intervention, Percutaneous balloon commissurotomy,
Surgery, Indications for intervention, Medical therapy, Serial testing, Special patient populations |
Tricuspid disease
|
Tricuspid stenosis, Evaluation, Surgery, Percutaneous intervention, Indications for intervention,
Medical therapy, Tricuspid regurgitation, Evaluation, Natural history, Results of surgery, Indications for surgery, Medical therapy |
Combined and multiple valve diseases
|
Prosthetic valves
|
Choice of prosthetic valve, Management after valve replacement, Baseline assessment and modalities of follow-up, Antithrombotic management, Management of valve thrombosis, Management of thrombo-embolism,
Management of haemolysis and paravalvular leak, Management of bioprosthetic failure, Heart failure |
Management during non-cardiac surgery
|
Clinical predictors of increased perioperative cardiovascular risk, Preoperative clinical evaluation,
Specific valve lesions, Aortic stenosis, Mitral stenosis, Aortic regurgitation and mitral regurgitation,
Prosthetic valves, Endocarditis prophylaxis, Perioperative monitoring |
Management during pregnancy
|
Cardiac risk of pregnancy, Evaluation of the pregnant patient with heart valve disease, Specific risks related to pregnancy, Native valve disease, Patients with prosthetic valves, Treatment, Aims, Methods,
Management strategy, Delivery |